Inhibins, activins, and follistatins are all believed to play roles in the regulation of FSH secretion by the pituitary and in the paracrine regulation of testis function. Previous studies have resulted in conflicting data on the pattern of expression of the inhibin/activin subunits, and little information on expression of follistatin during fetal/ neonatal life. We have made use of new, highly specific monoclonal antibodies and fixed tissue sections from fetal, neonatal, and adult rats, and limited amounts of fetal and neonatal human testis, to undertake a detailed immunocytochemical study of the pattern of expression of these regulatory proteins.
than immunostaining for the ␣-subunit. The pattern of ␤B-immunostaining in postnatal samples paralleled that of the ␣-subunit. Immunostaining using antibodies against the ␤A-subunit did not produce any significant reaction product in any sample. Follistatin was undetectable in the fetal rat testis but appeared in the Leydig cells immediately after birth and its expression remained intense throughout postnatal development and in adult testis. No evidence was obtained for expression of either the inhibin/activin subunits or follistatin in the germ cells, peritubular myoid cells, or other interstitial cells in any of the sections examined. In the human fetal testis, both ␣-and ␤B-subunits were immunodetectable at 16, 18 , and 24 weeks gestation in Sertoli and Leydig cells, with stronger immunostaining in Sertoli cells at 24 weeks. Postnatally at 4 months, immunoexpression of the ␤B-subunit was no longer detectable, whereas the ␣-immunostaining became weaker but was still present in both Sertoli and Leydig cells. No positive immunostaining for ␤A-subunit or follistatin was detectable at any time point studied.
In conclusion, we have shown that, in the rat testis, the majority of inhibin ␣-subunit and inhibin/activin ␤B-subunit is immunolocalized to the fetal-type Leydig cells during fetal/neonatal life but, following birth, immunoexpression in the Sertoli cells of both subunits increases markedly while follistatin is immunodetectable only postnatally. (Endocrinology 138: 2136 -2147, 1997) I NHIBINS and activins are structurally related dimeric gonadal proteins with the ability to alter FSH secretion from pituitary glands (1, 2) . Inhibin selectively suppresses FSH secretion (2) , whereas activin can stimulate FSH release (3) . Inhibins are composed of an ␣-subunit and one of the two similar, but distinct ␤-subunits (␤A and ␤B). Activins are dimers of two ␤-subunits and the three possible activin dimers have been designated, activin A (␤A/␤A), activin B (␤A/␤B), and activin AB (␤A/␤B) (2) . Apart from their action on FSH secretion, the inhibins and activins have been shown to exert paracrine/autocrine effects within the gonads (4, 5) and other tissues (6) and have been proposed to have important paracrine function(s) during fetal development (7) . The proteins and messenger RNAs (mRNAs) of the three subunits of inhibin/activin have been localized in the immature and adult testis but little is known about the pattern of expression and function of these peptides in the fetal and neonatal gonads (8 -10) .
In the adult testis, inhibin is mainly synthesized by Sertoli cells with small amounts produced also in the Leydig cells (9 -11). Previous reports have described a similar pattern of expression in the fetal and neonatal testis; however, in the limited data presented the immunostaining in Leydig cells appeared to be more prominent in immature animals than in adults (9, 10) . A similar pattern of expression has also been reported for the primate (rhesus monkey and human) testis (8) . In the rat, studies have indicated that immunodetectable levels of the inhibin/activin subunits as well as their mRNA levels in the testis vary greatly with age (9, 10) . Specific measurement of the levels of inhibin in circulation have usually been based on assays that appear not to distinguish between dimeric (active) inhibin and free ␣-subunit (12), a problem which has now been resolved by the development of highly specific monoclonal antibodies that have been selected to recognize only the bioactive inhibin dimers (13) . Results using these assays have indicated that the physio-logically important form of inhibin in the male is inhibin B (14) . Immunocytochemical data generated using polyclonal antisera to inhibin/activin peptides now merits revaluation.
Follistatins are a group of proteins reported to have the ability to suppress FSH secretion, but which are structurally unrelated to inhibins. So far, nine different-sized follistatin proteins have been described, all derived from a single gene by alternative splicing of its mRNA or posttranslational modifications (15) . Studies by Kogawa and Nakamura and their colleagues (16, 17) have shown that follistatins bind to the activins and to lesser extent to inhibins (18) . The role of the follistatins are not as yet completely elucidated, but the available data suggest that they may function primarily as regulators of activin bioavailability rather than as simple carrier molecules (19, 20) . Follistatins are reported to be expressed both in the pituitary gland (16) and in the adult testis (21) but not in the fetal testis (22) .
In the present study, we have used fixed tissue sections to undertake immunolocalization with new highly specific monoclonal antibodies raised against each of the inhibin/ activin subunits and follistatin to study the ontogeny and cellular localization of the inhibin/activin subunits and follistatin in fetal testis from rat and human and to compare this to the postnatal rat testis. The results obtained have demonstrated that, in the rat, the majority of inhibin/activin is immunolocalized to the Leydig cells during fetal life, but, after birth, immunoexpression in the Sertoli cells becomes more significant. We believe this is the first detailed study describing the pattern of expression of immunodetectable inhibin/activin subunits and follistatin during fetal and neonatal life.
Materials and Methods

Animals, treatments, and tissue recovery
Adult female rats were placed in individual cages with male rats and checked for the presence of copulatory plugs each morning. The day when the plug was found was taken as day 0.5 post coitum (p.c.). Pregnant females were killed on different days of pregnancy by inhalation of carbon dioxide and subsequent cervical dislocation. Fetuses were examined under a dissecting microscope and the testes recovered. Fetal testes were immersion fixed in Bouin's solution for 1-2 h, and whole fetuses and postnatal testes were immersion fixed in Bouin's solution for 5-6 h before processing into paraffin wax (23) . Fetal age was confirmed by morphological examination of the fetuses (24) . Tissues were obtained from fetuses or fetal testis on days 13.5 p.c. to day 20.5 p.c. and postnatal testes from rats aged 3, 7, 16, 18, 27, and 90 (adult) days; in adults, testes were recovered following perfusion fixation via the dorsal aorta as described previously (23) . Sections from at least three different animals were examined at each age.
Human fetal and postnatal testes were obtained from an archive collection at the Human Genetics Unit, Western General Hospital, Edinburgh, UK, and were derived from routine autopsies performed between 1990 and 1993. Testes from fetuses of 16, 18, and 24 (n ϭ 2) weeks gestation and testes from 4-month-old neonates (n ϭ 2) had been fixed in neutral buffered formaldehyde and were processed as above.
Immunocytochemistry
Sections (5 microns) were mounted on slides coated with 3-aminopropyl triethoxy-silane (TESPA; Sigma Chemical Co., St. Louis, MO) and dried overnight at 50 C. Before incubation with primary antibody, sections were dewaxed, rehydrated, in graded ethanols, washed in water and TBS (0.05 m Tris-HCl pH 7.4, 0.85% NaCl) following by blocking endogenous peroxidase by incubating the section for 30 min in 1% H 2 O 2 in TBS. Sections were subjected to antigen retrieval (25) by microwaving in 0.01 m citrate buffer (pH 6.0) on full power for 20 min, and thereafter left standing for 20 min without disturbance. Sections were then washed for 5 min in TBS and blocked using normal rabbit serum (Dako, High Wycombe, Buckinghamshire, UK) diluted 1:5 in TBS. Purified monoclonal antibodies directed against ␣-subunit [(26), code 173/9K] were used at a concentration of 2 g/ml and antibodies directed against the ␤B-subunit, which had a 1% cross-reaction with ␤A-subunit, [(27), code 12/13] at a concentration of 0.12 g/ml. Monoclonal antibodies specific for the ␤A-subunit [(28), code E4] were used at a range of concentrations between 0.74 and 37 g/ml. Antibodies directed against recombinant FS-288 follistatin (code 17/2; Evans and Groome, unpublished) were used at a concentration of 70 g/ml; this antibody will recognize follistatin even when bound to activin (L. R. Evans, unpublished). The immunostaining procedure was similar with all antibodies that were diluted in TBS containing normal rabbit serum (5:1, vol/vol) before incubation on sections under plastic coverslips overnight at 4 C. The following day coverslips were removed, sections washed twice in TBS (5 min each wash), incubated for 30 min with biotinylated rabbit antimouse immunoglobulins (Dako) diluted 1:500 in TBS and then washed again in TBS (2 ϫ 5 min). For detection of bound antibodies, sections were first incubated with avidin-biotin complex conjugated with horseradish peroxidase for 30 min and washed twice in TBS (5 min each). Colour reaction product was developed by incubating sections in a mixture of 0.05% (wt/vol) 3,3Ј-diaminobenzidine tetra-hydrochloride (DAB, Sigma) in 0.05 m Tris-HCl, pH 7.4, and 0.01% hydrogen peroxide. After 5-15 min, sections were washed in distilled water, counterstained with hematoxylin, dehydrated in graded ethanols, cleared in xylene and coverslipped using Pertex mounting medium (CellPath plc, Hemel Hempstead, UK). Specificity of the antibodies was controlled by using normal mouse serum instead of primary antibodies and by preabsorbing the antibodies with the corresponding peptide. 
No positive signal was obtained using antibodies directed against the ␤ A subunit. 
Coimmunolocalization of inhibin-␣ and 3␤-HSD
To detect inhibin ␣-subunit and the steroidogenic enzyme 3␤-hydroxysteroid dehydrogenase (3␤-HSD) simultaneously in one section, double fluorescent immunostaining was performed. Antibodies raised in rabbits, against human 3␤-HSD (29), were kindly donated by Professor Ian Mason (University of Edinburgh, Edinburgh, UK). Tissue sections were blocked with normal goat serum and incubated with the mixture of both primary antibodies (anti 3␤-HSD was used at a dilution of 1:1000 and anti ␣-inhibin at a dilution of 1:500) overnight at 4 C. Incubation with primary antibodies was followed by two washes in TBS and incubation with a mixture of fluorescent secondary antibodies (goat antimouse FITC conjugated and goat antirabbit TRITC conjugated, both from Sigma) at a dilution of 1:20 for 1 h at room temperature. Sections were washed again three times in TBS and coverslipped using glycerol gelatin and examined under UV light.
Analysis and photography
Images were captured into a Macintosh PowerPC computer using an Olympus Provis Image analysis system (Olympus Optical Co., London) equipped with a Kodak DCS420 camera (Eastman Kodak, Rochester, NY). For comparative assessment, the intensity of immunopositive staining was given a score as follows: Ϫ negative, Ϯ barely detectable ϩ faint, ϩϩ clear positive, ϩϩϩ intense positive.
Results
The intensity of immunostaining observed for all sections of rat testes is summarized in Table 1 .
Expression of the ␣-subunit
Positive immunostaining for inhibin ␣-subunit was first detectable in the fetal rat testis on day 14.5 ( Fig. 1a) , the earliest age at which the testis could be morphologically distinguished from the ovary. At this age, the immunostaining appeared to be equally intense (ϩ) in Sertoli and interstitial cells. However, on day 15.5 ( Fig. 1b) , the immunostaining was more intense in the interstitial cells (ϩϩ) than in Sertoli cells (ϩ, arrowheads). Thereafter, the immunostaining remained very intense in the fetal Leydig cells (ϩϩϩ) but was barely detectable (Ϯ) in the fetal Sertoli cells (Fig. 1d) . Double immunofluoresence staining with anti-␣-subunit and anti-3␤-HSD antibodies clearly showed colocalization of 3␤-HSD and ␣-subunit (Fig. 2) and therefore demonstrated that steroidogenically active Leydig cells are the cells expressing inhibin ␣-subunit in the interstitium during fetal life. No positive immunostaining was detected in the fetal ovary at any age examined (not shown).
Postnatally, the ␣-subunit immunostaining in the interstitium remained intense (ϩϩϩ) for several days after birth in the clusters of fetal-type Leydig cells (Fig. 3a, arrows) . With progressive age and replacement of the fetal Leydig cells by their adult-type counterparts, immunostaining reduced (ϩ/ ϩϩ, Fig. 3b ). In contrast, to fetal life immunoexpression of the ␣-subunit was increased in the Sertoli cells after birth and differences between the amount of immunostaining in individual tubule cross sections (i.e. stage-dependent expression) from ϩ to ϩϩ could already be distinguished on day 3 of life ( Fig. 3a) . Immunostaining of Sertoli cells was clearly stage specific around day 27 (Fig. 3c) ;. in the adult immunostaining of Sertoli cells in some tubules was very intense (ϩϩϩ), whereas others were barely positive (Ϯ) (Fig. 3d) .
Expression of ␤B-subunit
Immunocytochemistry with antibodies directed against the ␤B-subunit resulted in detection of positive immunostaining in the fetal Leydig cells on day 16.5 (ϩϩ, Fig. 4a ) but not on days 14.5 or 15.5 p.c. Immunostaining in the Leydig cells remained intense throughout fetal life (ϩϩϩ, Fig. 4, b and c) . Like that for the ␣-subunit, immunoexpression of the ␤B-subunit remained intense postnatally in the fetal type-Leydig cells but became much weaker once these cells were replaced by the adult generation of Leydig cells (Fig. 5, compare c ϩ with a ϩϩϩ) . Immunostaining for the ␤B-subunit was also observed within the tubules in the cytoplasm of Sertoli cells, however, this staining was very weak (Ϯ) throughout fetal development; no positive immunostaining was observed in fetal ovaries (not shown). Postnatally, the immunostaining in the Sertoli cells became more prominent soon after birth and remained prominent throughout postnatal development (Fig. 5) . Like the ␣-subunit, immunostaining for ␤B-subunit in the adult testis was stage dependent in Sertoli cells (ϩ to ϩϩϩ), with some immunostaining also observed in interstitial cells (ϩ).
Expression of inhibin subunits in human fetal and neonatal testes
In the human testis at 16 weeks gestation (Fig. 6, a and  c) , the immunodetectable ␣-and ␤B-inhibin subunits were present in both interstitial and Sertoli cells with similar intensity (ϩϩ). By 24 weeks (Fig. 6, b and d) , most Sertoli cells appeared to contain more immunoreactive protein (ϩϩ/ϩϩϩ) than did the Leydig cells (ϩ/ϩϩ), and this was also the case for immunoexpression of ␣-subunit in the two postnatal samples examined (Fig. 6e) . These results are consistent with the different time scales of development and maturation of the rat and human gonad. In the human, gonadal differentiation starts during the first trimester (30) . FSH production and secretion in the human fetus starts at around week 12 of pregnancy and increased FSH secretion may be the trigger for the expression of inhibin/activin subunits in Sertoli cells. As the youngest testis studied was from a 16-week-old fetus, it is not known if, like in the rat, the primary source of inhibin/ activin subunits at the very earliest stages of gonadal differentiation before onset of FSH secretion are Leydig cells. The immunoexpression of ␣-and ␤B-subunits in the human testis appeared to decline after birth, possibly as a consequence of reduced FSH secretion and production (31) .
␤A-subunit
Immunocytochemistry using a range of dilutions of antibodies specific for the ␤A-subunit failed to show any specific signal above background in any of the sections of rat or human testes examined.
Follistatin
Immunostaining for follistatin in the fetal rat testis failed to detect any positive signal at any age. During neonatal life, positive immunostaining (ϩϩϩ) was detected in clusters of fetal-type Leydig cells (Fig. 7) and in their adult-type counterparts (ϩϩϩ) at all ages examined. No positive signal for follistatin was detected in the limited number of sections available from the fetal or neonatal humans.
Discussion
Inhibins and activins are dimeric glycoproteins produced mainly in the gonads (2) . Initially they were recognized as gonadal regulators of FSH secretion by the pituitary gland , 16 weeks; d, 24 weeks) . Postnatally, immunoexpression of ␣-subunit declined but was still detectable in both Sertoli and interstitial cells (e), whereas the ␤B-subunit was no longer detectable (not shown). Immunostaining with preabsorbed antibodies against ␣-subunit did not result in any positive staining (f). Magnification, ϫ300.
with inhibin exhibiting a specific inhibitory role on FSH secretion (2), whereas activin has the capacity to stimulate the release of FSH (3). Several studies have suggested that, apart from their action(s) on the secretion of FSH, inhibins and activins have important paracrine regulatory roles in several tissues/organs during fetal, neonatal, and adult life (5, 32).
Several studies have also reported that expression of the inhibin/activin subunits occurs in testicular interstitial cells both prenatally and postnatally in the rat (9, 10) and primate (8) , but the results are not consistent between different reports. Studies by Roberts and co-workers (9) have detected ␣-subunit immunoexpression in both Sertoli and interstitial FIG. 7 . Follistatin immunoexpression was first detectable immediately after birth in the fetal generation of Leydig cells (a, day 7, arrows) and immunostaining was equally intense in the adult generation of Leydig cells when they appeared (b, day 27) and remained intense to adulthood (not shown). Magnification, ϫ200. cells in 12-day-old rats with the stronger staining being in the Sertoli cells. In these animals, immunostaining with antibodies directed against the ␤B-subunit resulted in a similar intensity of staining in the interstitial and Sertoli cells but did not detect any signal in clusters of Leydig cells. However, Shaha et al. (10) did not detect any significant immunoexpression of either ␣-or ␤B-subunits in interstitial cells of fetal (day 18 p.c.) and neonatal testes (days 1 and 7) . In contrast, Roberts and co-workers (22, 33) observed expression of the mRNA for the ␣-subunit in both interstitial and intratubular cells from day 14.5 p.c. onwards but were able to detect ␤B-subunit mRNA only in the intratubular compartment from day 14.5 p.c. onwards and found ␤A-subunit mRNA in the interstitial compartment just before birth in the rat. In the human and rhesus monkey, Rabinovici et al. (8) reported strong expression of both ␣-and ␤B-subunits proteins in the interstitial cells during fetal life with the ␣-subunit also being expressed in the Sertoli cells, whereas the expression of ␤B-subunit appeared to be confined to the Leydig cells. The results obtained in the present study where highly specific monoclonal antibodies were used, demonstrate intense immunostaining for both ␣-and ␤B-subunits in the interstitial cells within the fetal rat testis. mRNA for ␣-inhibin was also localized to the interstitial compartment (unpublished observations). These results are in accordance with the findings of Rabinovici et al. (8) for primate testis and with the results from Roberts and Barth (22) on mRNA expression in the rat testis. However, in the paper by Shaha et al. (10) in which the results for the fetal testis were confined to frozen sections of testes from day 18 p.c. fetuses, immunostaining was most apparent around the base of the seminiferous cords and interstitial staining was not prominent in fetal Leydig cells. This difference may be explained by the poor preservation of the tissue seen in the frozen sections. In the present study in which fixed tissues were used, double immunoflourescent staining using an anti-3␤-HSD antibody clearly showed exclusive colocalization of ␣-subunit and 3␤-HSD in the same cells on day 17.5 p.c., confirming that steroidogenically active Leydig cells were the only cells expressing inhibin subunits in the interstitial compartment at this age.
Immunoexpression of ␣-subunit was evident at a very early stage of testicular development, closely following the formation of the testicular cords. Immunoexpression of the ␤B-subunit was only detectable 2 days after that of the ␣-subunit and ␤A-subunit was undetectable in all the testes examined. It is possible that the early onset of the ␣-subunit synthesis is a part of a protective mechanism ensuring the formation of inhibin rather than activin once ␤-subunit expression commences. The detection of immunostaining for the ␤B-subunit in the fetal rat testis on day 16.5 p.c. would be consistent with the formation of inhibin B within the fetal gonad. However, on this day the expression of both subunits was confined to the fetal Leydig cells and occurred at a time when FSH expression is not yet detectable (34, 35) . Several studies have demonstrated the potential effects of inhibins/ activins on Sertoli cell proliferation (36, 37) and on the function of the adult type Leydig cell (4, 38) . However, studies using mice in which the ␣-subunit of inhibin has been knocked out suggest that inhibin ␤B is not essential for testicular development during fetal life as these mice have an apparently normal testis at the time of birth and are initially fertile although they subsequently develop gonadal tumors (39) .
In the present study, we found that, in the rat, the patterns of expression of both the ␣-and ␤B-subunits changed dramatically after birth. While the level of immunostaining in the clusters of fetal type Leydig cells remained high, expression of the ␣-subunit in Sertoli cells increased dramatically and was clearly increased on day 3 of life. The cause of this increase is unknown, but it could well be connected changes in the levels of circulating FSH as this is known to stimulate inhibin/activin production in the testis (40) . In the rat fetus, FSH is first detectable around day 19.5 p.c. (34, 35) rises just before birth, and continues to increase during neonatal life.
Follistatins were originally identified as proteins, like inhibins, with the ability to suppress FSH secretion (41) . However, additional studies have suggested that their primary role is to bind activins (16, 17) to prevent their biological effects (19, 20) . Follistatin proteins are expressed in the adult testis (21) and pituitary gland (16) as detected by immunocytochemistry, but studies by Roberts and Barth (22) have failed to detect mRNA expression in the fetal rat testis. The immunocytochemical study presented in this paper confirmed their findings and have failed to detect follistatin in the fetal rat or human testis at any age using specific immunocytochemistry. We conclude that activin is either required in the fetal testis for normal development or alternatively that no bioactive activin is produced at this time and therefore there is no need for synthesis of follistatins to prevent its action. Postnatally, the expression of follistatin was detectable in the Leydig cells immediately after birth. This finding was rather surprising because, at that age, the Leydig cells are still of the fetal type, found prenatally. What triggers the presence of follistatin protein in these cells is not known. It is unlikely to be changes in LH, which regulates the steroidogenic function of Leydig cells during late fetal life (42), because LH is already present in the fetus on day 17.5 of gestation (34) . It has been reported that follistatin mRNA is present in Sertoli and germ cells but not Leydig cells in adult rat testis (43) ; the question of the cellular site of synthesis of the immunodetectable follistatin, and the control of its production, therefore, requires further investigation. Studies by Boitani and co-workers (36) have suggested that Sertoli cell proliferation is stimulated by activin in the presence of FSH. Therefore, we speculate that the expression of follistatin in the testis postnatally could be involved in regulation of the effects of activin on Sertoli cells. No follistatin was detected in any of the human tissue sections examined. The antibodies used were raised against human follistatin, making it unlikely that they did not detect the protein, suggesting rather that follistatin is not produced by the fetal and neonatal human testis, and that either activin may be important for fetal testicular development in the human or alternatively, that there is no bioactive activin produced in the human fetal testis and therefore there was no need for synthesis of follistatin to prevent its actions.
The fetal-type Leydig cells differ from their adult counterparts in several respects (42) . It is believed that, postnatally, the fetal Leydig cells do not transform into their adult type counterparts but are replaced by new adult-type of
